CSIMarket
 


Atara Biotherapeutics, Inc.  (ATRA)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Atara Biotherapeutics's Leverage Ratio

ATRA's quarterly Leverage Ratio and Total Liabilities, Equity growth




ATRA Leverage Ratio (Mar 31 2019)
I. Quarter
(Dec 31 2018)
IV. Quarter
(Sep 30 2018)
III. Quarter
(Jun 30 2018)
II. Quarter
(Mar 31 2018)
I. Quarter
Y / Y Equity Change -35.35 % 90.51 % 95.7 % 104.62 % 88.38 %
Y / Y Total Liabilities Change 47.86 % -5.95 % 52.01 % 45.79 % 220.64 %
Leverage Ratio MRQ 0.14 0.1 0.09 0.07 0.06
Overall Ranking # # # # #
Seq. Equity Change -16.21 % -15.93 % -10.93 % 3.03 % 146.92 %
Seq. Total Liabilities Change 20.79 % -6.4 % 7.56 % 21.6 % -23.17 %



Leverage Ratio first quarter 2019 Comment
Due to net new borrowings of 20.79%, Leverage Ratio detoriated to 0.14, above company's average Leverage Ratio.

Within Biotechnology & Drugs industry in the first quarter 2019, 34 other companies have achieved lower Leverage Ratio than Atara Biotherapeutics. While total ranking remained unchanged compare to previous quarter at no. .

Explain Leverage Ratio?
Who are ATRA Customers?
Leverage Ratio first quarter 2019 Company Ranking
Within: No.
Biotechnology & Drugs Industry # 35
Healthcare Sector # 103
Overall Market # 242


Leverage Ratio Statistics
High Average Low
0.2 0.07 0.02
(Dec 31 2017)  




Financial Statements
Atara Biotherapeutics's Equity $ 284 Millions Visit ATRA's Balance sheet
Atara Biotherapeutics's Total Liabilities $ 41 Millions Visit ATRA's Balance sheet
Source of ATRA's Sales Visit ATRA's Sales by Geography




Companies with similar Leverage Ratio in the quarter endingMar 31 2019, within Biotechnology & Drugs Industry Leverage RatioMar 31 2019 MRQ Total LiabilitiesMar 31 2019 MRQ Equity
Allena Pharmaceuticals, Inc.  0.39 $ 15.260  Millions$ 38.679  Millions
Aclaris Therapeutics, Inc.  0.39 $ 70.930  Millions$ 182.253  Millions
Immunomedics Inc  0.39 $ 70.246  Millions$ 181.804  Millions
Meridian Bioscience Inc  0.38 $ 69.843  Millions$ 181.645  Millions
Pulmatrix, Inc.  0.37 $ 3.795  Millions$ 10.196  Millions
Vericel Corp  0.37 $ 38.174  Millions$ 103.055  Millions
Aerie Pharmaceuticals Inc  0.37 $ 70.900  Millions$ 192.150  Millions
Assembly Biosciences, Inc.  0.36 $ 68.846  Millions$ 190.401  Millions
Amarillo Biosciences Inc  0.36 $ 0.198  Millions$ 0.552  Millions
Novus Therapeutics, Inc.  0.35 $ 3.522  Millions$ 9.929  Millions
Urovant Sciences Ltd.  0.34 $ 25.351  Millions$ 74.770  Millions
Homology Medicines, Inc.  0.34 $ 58.762  Millions$ 174.264  Millions
Dare Bioscience, Inc.  0.33 $ 1.239  Millions$ 3.780  Millions
Gritstone Oncology, Inc.  0.33 $ 43.265  Millions$ 132.222  Millions
Momenta Pharmaceuticals Inc  0.32 $ 135.892  Millions$ 422.558  Millions
Neuralstem, Inc.  0.32 $ 1.051  Millions$ 3.272  Millions
Pds Biotechnology Corp  0.31 $ 7.644  Millions$ 24.448  Millions
Protagonist Therapeutics, Inc  0.31 $ 31.423  Millions$ 100.825  Millions
Cellular Biomedicine Group, Inc.  0.31 $ 28.828  Millions$ 92.511  Millions
Crispr Therapeutics Ag  0.31 $ 118.063  Millions$ 379.810  Millions
Denali Therapeutics Inc.  0.31 $ 159.948  Millions$ 516.648  Millions
Celldex Therapeutics, Inc.  0.31 $ 34.884  Millions$ 112.693  Millions
Intellia Therapeutics, Inc.  0.30 $ 80.025  Millions$ 264.338  Millions
Cohbar, Inc.  0.27 $ 4.296  Millions$ 16.015  Millions
Aravive, Inc.  0.27 $ 14.568  Millions$ 54.961  Millions
Trovagene, Inc.  0.26 $ 2.531  Millions$ 9.686  Millions
Aptose Biosciences Inc.  0.25 $ 3.814  Millions$ 15.424  Millions
Repligen Corp  0.24 $ 152.708  Millions$ 625.025  Millions
Nantkwest, Inc.  0.24 $ 40.453  Millions$ 167.808  Millions
Diffusion Pharmaceuticals Inc.  0.23 $ 2.923  Millions$ 12.955  Millions


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

BENH's Profile

Stock Price

BENH's Financials

Business Description

Fundamentals

Charts & Quotes

BENH's News

Suppliers

BENH's Competitors

Customers & Markets

Economic Indicators

BENH's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071